Last seen: Apr 16, 2026
A helpful way to think about early start and late finish is to connect them directly to how the network diagram is built during the planning phase. Af...
The tension between technical readiness and market enthusiasm is a significant challenge in medical device development. Early client interest can vali...
That is an interesting question because the answer depends on what someone expects a certification to represent. From one perspective, the Google Proj...
An interesting way to approach this question is to separate frequency from severity. In most projects, resource risk is the most visible and therefore...
Risk transference in the pharmaceutical and medical device industry often appears in structured partnerships where a third party assumes defined opera...
Hello everyone, My name is Qossay Sawalha, and I am currently a master’s student in the Mechanical Engineering department at NJIT. I look forward to...
Another view, however, based on the principle that the DHF should be kept as an active engineering record and not just an archive, is that documentati...
A balanced Design Development Plan is more focused on priorities than on task-level detail. This allows companies to set key regulatory, performance a...
An alternative way of thinking about design reviews is not as a checklist where team members review documents and complete forms, but as an active ses...
One view is that the best way for organizations to balance innovation with compliance is for Design Controls to be part of the organizations' regular ...
One way to look at this issue is through how the PDCA cycle separates planning from execution. In the accompanying slides it states that the design in...
The guidance states that the methods used for verification and validation do not need FDA approval before use. However, it says that the methods must ...
In the event of verification failure, the scope of pressurization is often to solve the visible problem, not to see why it did not meet the requiremen...
In medical device development, organizational structure strongly influences how smoothly technical work, testing, and regulatory activities stay align...
The key differences are whether the device represents such a meaningful change that it raises new questions of safety and effectiveness for patients, ...